Pharmaceutical Commerce - February 2024

Click the title above for a link to open the Pharmaceutical Commerce February 2024 issue in an interactive PDF format.

The February issue is centered around third-party logistics providers, including new dynamics and future trends that affect this key supply chain link.

Pharma Commerce's new style is built off of the back of our new and improved editorial calendar.

Pharma Commerce travels to Orlando for a pulse-check on this fast-evolving landscape in patient care.

And the need to boost awareness of this critical healthcare resource.

An analysis of the two main new models for pharmacy—unique direct—to-consumer for brands and cash pay for generics—and what members of industry think about them.

A dive into this market reveals that the latest numbers yield promising results—a global value of a worldwide $1.6 trillion—but it will continue to be attributed to past, present, and future healthcare spending.

Leading experts in the sector explore the value of third-party logistics providers when it comes to fortifying pharmaceutical supply chains.

In order to provide both profitability and medication access, a balancing act is required.

Duplicate rebates have resulted in revenue leakage for manufacturers.

A look at the challenges that need to be addressed during the FDA stabilization period.